Whatever happened to the project to crack the wealthy world’s lock on mRNA vaccines?

Posted by on September 12, 2023 4:02 pm
Tags:
Categories: US National Stories

Gerhardt Boukes, chief scientist at Afrigen Biologics and Vaccines, formulates mRNA for use in a vaccine against COVID-19. The company — based in Cape Town, South Africa — is the linchpin of a global project to enable low- and middle-income countries to make mRNA vaccines against all manner of diseases.

Lower-income countries did not get the COVID vaccines they needed. So the World Bank and other partners tapped a South African company to cook up the (undisclosed) recipe for the Moderna mRNA vaccine.

(Image credit: Tommy Trenchard for NPR)

Leave a Reply

Your email address will not be published.